Cargando…
Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes
Betatrophin has recently been described as a key hormone to stimulate beta-cell mass expansion in response to insulin resistance and obesity in mice. The finding has generated an interest in the development of antidiabetic drugs with betatrophin as the active component. However, the circulating leve...
Autores principales: | Espes, Daniel, Martinell, Mats, Carlsson, Per-Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055101/ https://www.ncbi.nlm.nih.gov/pubmed/24963292 http://dx.doi.org/10.1155/2014/323407 |
Ejemplares similares
-
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
por: Espes, Daniel, et al.
Publicado: (2013) -
Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
por: Li, Sheyu, et al.
Publicado: (2016) -
Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
por: Trebotic, Lana Kosi, et al.
Publicado: (2015) -
Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism
por: Han, Cheng, et al.
Publicado: (2016) -
Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass
por: Elksnis, Andris, et al.
Publicado: (2019)